PROLOR Biotech (PBTH) announces that it achieved positive top-line results from a study of its...

|About: PROLOR Biotech Inc (PBTH)|By:, SA News Editor

PROLOR Biotech (PBTH) announces that it achieved positive top-line results from a study of its human growth hormone tested in a Phase II clinical study. The results indicate the firm's drug may be able to achieve the same results as currently marketed treatments with fewer injections required. Shares +3.8% premarket.